neuromodulation

ONWARD Medical has begun a global pivotal study for its ARC-IM system, an implantable device designed to manage blood pressure instability in spinal cord injury (SCI) patients. This system aims to address autonomic dysreflexia and orthostatic hypotension by delivering targeted spinal cord stimulation. The study seeks to demonstrate the ARC-IM system’s safety and efficacy, potentially leading to a new standard of care for autonomic dysfunction in SCI individuals.